DARA BioSciences (DARA) Misses Q1 EPS by 3c

Go back to DARA BioSciences (DARA) Misses Q1 EPS by 3c

DARA BioSciences Announces First Quarter 2015 Results

May 13, 2015 4:19 PM EDT

RALEIGH, NC -- (Marketwired) -- 05/13/15 -- DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced its first quarter 2015 results.

First Quarter 2015 Financial Snapshot
DARA reported net revenues of $652.2 thousand for the first quarter ended March 31, 2015 based on gross product sales in excess of $850 thousand, as compared to net revenues of... More

DARA BioSciences Announces Date and Time for Announcement of First Quarter 2015 Results

May 12, 2015 7:00 AM EDT

RALEIGH, NC -- (Marketwired) -- 05/12/15 -- DARA BioSciences, Inc. (NASDAQ: DARA), an oncology supportive care pharmaceutical company dedicated to providing health care professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatment, today announced that it will release financial results for the first quarter ended March 31, 2015, after the close of the market on Wednesday, May 13, 2015.

The Company will host a conference call for investors on Thursday, May 14, 2015, at 09:00 a.m. Eastern Time. To listen to the live call, individuals... More